Global PROteolysis Targeting Chimera PROTAC Market Research Report 2023(Status and Outlook)
- Published Date: 2023-08-20
- Report ID: 146592
- Pages: 250
-
Format:
Report Overview
A proteolysis targeting chimera (PROTAC) is a heterobifunctional small molecule composed of two active domains and a linker capable of removing specific unwanted proteins. Rather than acting as a conventional enzyme inhibitor, a PROTAC works by inducing selective intracellular proteolysis. PROTACs consist of two covalently linked protein-binding molecules: one capable of engaging an E3 ubiquitin ligase, and another that binds to a target protein meant for degradation. Recruitment of the E3 ligase to the target protein results in ubiquitination and subsequent degradation of the target protein by the proteasome. Because PROTACs need only to bind their targets with high selectivity (rather than inhibit the target protein's enzymatic activity), there are currently many efforts to retool previously ineffective inhibitor molecules as PROTACs for next-generation drugs.
Prudent Markets latest report provides a deep insight into the global PROteolysis Targeting Chimera PROTAC market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porters five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global PROteolysis Targeting Chimera PROTAC Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the PROteolysis Targeting Chimera PROTAC market in any manner.
Global PROteolysis Targeting Chimera PROTAC Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Arvinas
Kymera
C4 therapeutics
Captor therapeutics
Vividion
Cullgen
Pfizer
Merck
Genentech
AstraZeneca
Amgen
Bayer
Market Segmentation (by Type)
ARV-110
ARV-471
KYM-001
Others
Market Segmentation (by Application)
Oncology
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the PROteolysis Targeting Chimera PROTAC Market
Overview of the regional outlook of the PROteolysis Targeting Chimera PROTAC Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value (USD Billion) data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porters five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the PROteolysis Targeting Chimera PROTAC Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of PROteolysis Targeting Chimera PROTAC
1.2 Key Market Segments
1.2.1 PROteolysis Targeting Chimera PROTAC Segment by Type
1.2.2 PROteolysis Targeting Chimera PROTAC Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PROteolysis Targeting Chimera PROTAC Market Overview
2.1 Global Market Overview
2.1.1 Global PROteolysis Targeting Chimera PROTAC Market Size (M USD) Estimates and Forecasts (2018-2029)
2.1.2 Global PROteolysis Targeting Chimera PROTAC Sales Estimates and Forecasts (2018-2029)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PROteolysis Targeting Chimera PROTAC Market Competitive Landscape
3.1 Global PROteolysis Targeting Chimera PROTAC Sales by Manufacturers (2018-2023)
3.2 Global PROteolysis Targeting Chimera PROTAC Revenue Market Share by Manufacturers (2018-2023)
3.3 PROteolysis Targeting Chimera PROTAC Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global PROteolysis Targeting Chimera PROTAC Average Price by Manufacturers (2018-2023)
3.5 Manufacturers PROteolysis Targeting Chimera PROTAC Sales Sites, Area Served, Product Type
3.6 PROteolysis Targeting Chimera PROTAC Market Competitive Situation and Trends
3.6.1 PROteolysis Targeting Chimera PROTAC Market Concentration Rate
3.6.2 Global 5 and 10 Largest PROteolysis Targeting Chimera PROTAC Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 PROteolysis Targeting Chimera PROTAC Industry Chain Analysis
4.1 PROteolysis Targeting Chimera PROTAC Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of PROteolysis Targeting Chimera PROTAC Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 PROteolysis Targeting Chimera PROTAC Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global PROteolysis Targeting Chimera PROTAC Sales Market Share by Type (2018-2023)
6.3 Global PROteolysis Targeting Chimera PROTAC Market Size Market Share by Type (2018-2023)
6.4 Global PROteolysis Targeting Chimera PROTAC Price by Type (2018-2023)
7 PROteolysis Targeting Chimera PROTAC Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global PROteolysis Targeting Chimera PROTAC Market Sales by Application (2018-2023)
7.3 Global PROteolysis Targeting Chimera PROTAC Market Size (M USD) by Application (2018-2023)
7.4 Global PROteolysis Targeting Chimera PROTAC Sales Growth Rate by Application (2018-2023)
8 PROteolysis Targeting Chimera PROTAC Market Segmentation by Region
8.1 Global PROteolysis Targeting Chimera PROTAC Sales by Region
8.1.1 Global PROteolysis Targeting Chimera PROTAC Sales by Region
8.1.2 Global PROteolysis Targeting Chimera PROTAC Sales Market Share by Region
8.2 North America
8.2.1 North America PROteolysis Targeting Chimera PROTAC Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe PROteolysis Targeting Chimera PROTAC Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific PROteolysis Targeting Chimera PROTAC Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America PROteolysis Targeting Chimera PROTAC Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa PROteolysis Targeting Chimera PROTAC Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Arvinas
9.1.1 Arvinas PROteolysis Targeting Chimera PROTAC Basic Information
9.1.2 Arvinas PROteolysis Targeting Chimera PROTAC Product Overview
9.1.3 Arvinas PROteolysis Targeting Chimera PROTAC Product Market Performance
9.1.4 Arvinas Business Overview
9.1.5 Arvinas PROteolysis Targeting Chimera PROTAC SWOT Analysis
9.1.6 Arvinas Recent Developments
9.2 Kymera
9.2.1 Kymera PROteolysis Targeting Chimera PROTAC Basic Information
9.2.2 Kymera PROteolysis Targeting Chimera PROTAC Product Overview
9.2.3 Kymera PROteolysis Targeting Chimera PROTAC Product Market Performance
9.2.4 Kymera Business Overview
9.2.5 Kymera PROteolysis Targeting Chimera PROTAC SWOT Analysis
9.2.6 Kymera Recent Developments
9.3 C4 therapeutics
9.3.1 C4 therapeutics PROteolysis Targeting Chimera PROTAC Basic Information
9.3.2 C4 therapeutics PROteolysis Targeting Chimera PROTAC Product Overview
9.3.3 C4 therapeutics PROteolysis Targeting Chimera PROTAC Product Market Performance
9.3.4 C4 therapeutics Business Overview
9.3.5 C4 therapeutics PROteolysis Targeting Chimera PROTAC SWOT Analysis
9.3.6 C4 therapeutics Recent Developments
9.4 Captor therapeutics
9.4.1 Captor therapeutics PROteolysis Targeting Chimera PROTAC Basic Information
9.4.2 Captor therapeutics PROteolysis Targeting Chimera PROTAC Product Overview
9.4.3 Captor therapeutics PROteolysis Targeting Chimera PROTAC Product Market Performance
9.4.4 Captor therapeutics Business Overview
9.4.5 Captor therapeutics PROteolysis Targeting Chimera PROTAC SWOT Analysis
9.4.6 Captor therapeutics Recent Developments
9.5 Vividion
9.5.1 Vividion PROteolysis Targeting Chimera PROTAC Basic Information
9.5.2 Vividion PROteolysis Targeting Chimera PROTAC Product Overview
9.5.3 Vividion PROteolysis Targeting Chimera PROTAC Product Market Performance
9.5.4 Vividion Business Overview
9.5.5 Vividion PROteolysis Targeting Chimera PROTAC SWOT Analysis
9.5.6 Vividion Recent Developments
9.6 Cullgen
9.6.1 Cullgen PROteolysis Targeting Chimera PROTAC Basic Information
9.6.2 Cullgen PROteolysis Targeting Chimera PROTAC Product Overview
9.6.3 Cullgen PROteolysis Targeting Chimera PROTAC Product Market Performance
9.6.4 Cullgen Business Overview
9.6.5 Cullgen Recent Developments
9.7 Pfizer
9.7.1 Pfizer PROteolysis Targeting Chimera PROTAC Basic Information
9.7.2 Pfizer PROteolysis Targeting Chimera PROTAC Product Overview
9.7.3 Pfizer PROteolysis Targeting Chimera PROTAC Product Market Performance
9.7.4 Pfizer Business Overview
9.7.5 Pfizer Recent Developments
9.8 Merck
9.8.1 Merck PROteolysis Targeting Chimera PROTAC Basic Information
9.8.2 Merck PROteolysis Targeting Chimera PROTAC Product Overview
9.8.3 Merck PROteolysis Targeting Chimera PROTAC Product Market Performance
9.8.4 Merck Business Overview
9.8.5 Merck Recent Developments
9.9 Genentech
9.9.1 Genentech PROteolysis Targeting Chimera PROTAC Basic Information
9.9.2 Genentech PROteolysis Targeting Chimera PROTAC Product Overview
9.9.3 Genentech PROteolysis Targeting Chimera PROTAC Product Market Performance
9.9.4 Genentech Business Overview
9.9.5 Genentech Recent Developments
9.10 AstraZeneca
9.10.1 AstraZeneca PROteolysis Targeting Chimera PROTAC Basic Information
9.10.2 AstraZeneca PROteolysis Targeting Chimera PROTAC Product Overview
9.10.3 AstraZeneca PROteolysis Targeting Chimera PROTAC Product Market Performance
9.10.4 AstraZeneca Business Overview
9.10.5 AstraZeneca Recent Developments
9.11 Amgen
9.11.1 Amgen PROteolysis Targeting Chimera PROTAC Basic Information
9.11.2 Amgen PROteolysis Targeting Chimera PROTAC Product Overview
9.11.3 Amgen PROteolysis Targeting Chimera PROTAC Product Market Performance
9.11.4 Amgen Business Overview
9.11.5 Amgen Recent Developments
9.12 Bayer
9.12.1 Bayer PROteolysis Targeting Chimera PROTAC Basic Information
9.12.2 Bayer PROteolysis Targeting Chimera PROTAC Product Overview
9.12.3 Bayer PROteolysis Targeting Chimera PROTAC Product Market Performance
9.12.4 Bayer Business Overview
9.12.5 Bayer Recent Developments
10 PROteolysis Targeting Chimera PROTAC Market Forecast by Region
10.1 Global PROteolysis Targeting Chimera PROTAC Market Size Forecast
10.2 Global PROteolysis Targeting Chimera PROTAC Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe PROteolysis Targeting Chimera PROTAC Market Size Forecast by Country
10.2.3 Asia Pacific PROteolysis Targeting Chimera PROTAC Market Size Forecast by Region
10.2.4 South America PROteolysis Targeting Chimera PROTAC Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of PROteolysis Targeting Chimera PROTAC by Country
11 Forecast Market by Type and by Application (2024-2029)
11.1 Global PROteolysis Targeting Chimera PROTAC Market Forecast by Type (2024-2029)
11.1.1 Global Forecasted Sales of PROteolysis Targeting Chimera PROTAC by Type (2024-2029)
11.1.2 Global PROteolysis Targeting Chimera PROTAC Market Size Forecast by Type (2024-2029)
11.1.3 Global Forecasted Price of PROteolysis Targeting Chimera PROTAC by Type (2024-2029)
11.2 Global PROteolysis Targeting Chimera PROTAC Market Forecast by Application (2024-2029)
11.2.1 Global PROteolysis Targeting Chimera PROTAC Sales (K MT) Forecast by Application
11.2.2 Global PROteolysis Targeting Chimera PROTAC Market Size (M USD) Forecast by Application (2024-2029)
12 Conclusion and Key Findings
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
